Tonghua Dongbao Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.76%

Tonghua Dongbao Pharmaceutical Co Ltd (600867) has an Asset Resilience Ratio of 0.76% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 600867 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥63.00 Million

≈ $9.22 Million USD Cash + Short-term Investments

Total Assets

CN¥8.25 Billion

≈ $1.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Tonghua Dongbao Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Tonghua Dongbao Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tonghua Dongbao Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600867 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥63.00 Million	0.76%
Total Liquid Assets	CN¥63.00 Million	0.76%

Asset Resilience Insights

Limited Liquidity: Tonghua Dongbao Pharmaceutical Co Ltd maintains only 0.76% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Tonghua Dongbao Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tonghua Dongbao Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%

Annual Asset Resilience Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Tonghua Dongbao Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.80%	CN¥63.22 Million ≈ $9.25 Million	CN¥7.91 Billion ≈ $1.16 Billion	+0.05pp
2024-12-31	0.75%	CN¥55.40 Million ≈ $8.11 Million	CN¥7.38 Billion ≈ $1.08 Billion	+0.04pp
2023-12-31	0.71%	CN¥55.52 Million ≈ $8.12 Million	CN¥7.77 Billion ≈ $1.14 Billion	-0.15pp
2022-12-31	0.87%	CN¥58.46 Million ≈ $8.55 Million	CN¥6.75 Billion ≈ $987.78 Million	+0.30pp
2021-12-31	0.57%	CN¥37.00 Million ≈ $5.41 Million	CN¥6.52 Billion ≈ $954.10 Million	-2.02pp
2020-12-31	2.59%	CN¥150.37 Million ≈ $22.00 Million	CN¥5.80 Billion ≈ $849.20 Million	-3.32pp
2018-12-31	5.91%	CN¥323.00 Million ≈ $47.27 Million	CN¥5.46 Billion ≈ $799.46 Million	-0.65pp
2017-12-31	6.56%	CN¥312.00 Million ≈ $45.66 Million	CN¥4.75 Billion ≈ $695.47 Million	-1.99pp
2016-12-31	8.56%	CN¥400.00 Million ≈ $58.53 Million	CN¥4.68 Billion ≈ $684.10 Million	--

pp = percentage points

About Tonghua Dongbao Pharmaceutical Co Ltd

SHG:600867 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.14 Billion

CN¥14.61 Billion CNY

Market Cap Rank

#6085 Global

#1271 in China

Share Price

CN¥7.46

Change (1 day)

+1.22%

52-Week Range

CN¥7.37 - CN¥10.49

All Time High

CN¥23.57